News

UK researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means. The research is part of UK’s CURE Alliance team, which is uniting UK researchers across disciplines in the fight against the novel coronavirus.

“We are pleased to be able to offer this clinical trial to patients with COVID-19 in Kentucky. While there is no standard treatment for COVID-19, this trial gives us the ability to test multiple therapies rapidly in order to identify the most promising agents.”

The Kentucky Conference on Health Communication (KCHC), which was supposed to be held April 2-4, 2020, at the Hyatt Regency in Lexington, made the swift change to a virtual conference amid the COVID-19 pandemic.

It cannot be seen, smelled or tasted, and people are exposed by breathing radon in air when it comes in through gaps and cracks in their homes. It is the second-leading cause of lung cancer after tobacco smoking.

According to the report, confirmed COVID-19 cases in the Commonwealth would have reached a staggering 45,000 by April 25 without any state-imposed measures. For comparison, the current total of confirmed COVID-19 cases is fewer than 4,000.

A new study led by UK researcher April Young and Emory researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder (OUD).

The NIEHS has awarded the UK-SRC a five-year, $8.7 million grant to conduct research aimed at better understanding and minimizing the negative health and environmental impacts of chlorinated organic compounds found at Superfund sites.

During times of uncertainty, we — as a society — search for answers. COVID-19, first and foremost, is a public health crisis. But it also leaves us with pressing questions. UK experts can lend their knowledge and experience to help.

As the worldwide coronavirus COVID-19 pandemic continues to play out, researchers are among those working to find innovative solutions to help flatten the curve. Jamie Sturgill has created a new way to find biomarkers for lung disease -- by testing a person's breath.

“I am continually impressed and grateful every day for the effort and dedication of the staff of UK Healthcare’s clinical laboratories. They are in the lab working to improve the lives of patients 24/7 throughout the year.